Abstract: A method at a first computing device providing a local traffic service, the method including detecting a vehicle is transitioning to a region of control of a second local traffic service; and providing, to a second traffic management service, priority information for the vehicle.

Abstract: A modular machine-automation system includes a server module and a plurality of client modules. Each client module includes a housing having a first client module connection face with a first client signal transfer unit and a second client module connection face with a second client signal transfer, and a client bus switch-on unit. In an initialization mode, a client signal coupling unit in the client bus switch-on unit is configured to determine which client module connection face is connected to a server module connection face, either directly or via one or a plurality of further client modules, in order to switch to a first operating mode when the first client module connection face is coupled to the server module connection face, and to a second operating mode when the second client module connection face is coupled to the server module connection face.

Abstract: A method is related for operating a modular robot. The modular robot comprises a robot base, at least a robot arm arranged on the robot base and a controller. The robot arm comprises a plurality of modularly arrangeable arm modules. The controller carries out steps described herein. Allocation information is received from each of the arm modules in an allocation determining step. In an arm module base data determining step, arm module base data is determined for each arm module based on the allocation information. Further, a configuration of the modular robot is created from the association information and the arm module base data of each arm module in a configurating step, where the configuration is used to control the robot arm.

Abstract: A building panel is provided. The building panel includes an exterior wall portion, an interior wall portion, a pair of opposing sidewalls, a first end portion and an opposite second end portion. The pair of opposing sidewalls spacing apart the interior wall portion from the exterior wall portion to define a cavity therebetween. The exterior wall portion, the interior wall portion and the pair of opposing sidewalls are arcuate in shape to define the building panel. The first end portion has a slip lock slot extending between the pair of opposing sidewalls. The second end portion has a slip lock tab member extending between the pair of opposing sidewalls. The slip lock slot of the building panel is configured to receive the slip lock tab member of a second building panel to adjoin the first and second building panels in a continuous fashion.

Abstract: The invention relates to an electrolyte arrangement for a cell having at least one anode (1) and at least one cathode (3) comprising at least three superposed layers (2.1, 2.2, 2.3), wherein the middle layer (2.2) comprises a porous electrically nonconductive structure, and wherein a layer of a polymer-based electrolyte (2.1, 2.3) is arranged on both opposite sides of the porous electrically nonconductive structure, wherein at least one of the superposed layers (2.1, 2.2, 2.3) contains a ceramic material, wherein the ceramic material of the middle layer (2.2) is selected from metal ion-conductive ceramic material, a ceramic material which does not conduct metal ions, and/or mixtures thereof, and the ceramic material of the polymer-based electrolyte layer(s) (2.1, 2.3) is a metal ion-conductive ceramic material.

Abstract: In some examples, a wireless device includes a communication interface to communicate with a wireless network, and at least one processor configured to, receive, from an access point (AP), information including a network address policy of the wireless network. The at least one processor is configured to further, in response to the information including the network address policy, use an address of the wireless device according to the network address policy.

Abstract: A method at an infrastructure unit of signaling a presence of a vulnerable road user, the method including receiving at least one report from a sensor unit, the at least one report indicating the presence of the vulnerable road user; composing a message indicating the presence of the vulnerable road user; and transmitting the message to road users proximate the infrastructure unit on a channel.

Abstract: A building panel is provided. The building panel includes an exterior wall portion, an interior wall portion, a pair of opposing sidewalls, a first end portion and an opposite second end portion. The pair of opposing sidewalls spacing apart the interior wall portion from the exterior wall portion to define a cavity therebetween. The exterior wall portion, the interior wall portion and the pair of opposing sidewalls are arcuate in shape to define the building panel. The first end portion has a slip lock slot extending between the pair of opposing sidewalls. The second end portion has a slip lock tab member extending between the pair of opposing sidewalls. The slip lock slot of the building panel is configured to receive the slip lock tab member of a second building panel to adjoin the first and second building panels in a continuous fashion.

Abstract: A building panel is provided. The building panel includes an exterior wall portion, an interior wall portion, a pair of opposing sidewalls, a first end portion and an opposite second end portion. The pair of opposing sidewalls spacing apart the interior wall portion from the exterior wall portion to define a cavity therebetween. The exterior wall portion, the interior wall portion and the pair of opposing sidewalls are arcuate in shape to define the building panel. The first end portion has a slip lock slot extending between the pair of opposing sidewalls. The second end portion has a slip lock tab member extending between the pair of opposing sidewalls. The slip lock slot of the building panel is configured to receive the slip lock tab member of a second building panel to adjoin the first and second building panels in a continuous fashion.

Abstract: Described in exemplary embodiments herein are methods, compositions, and kits for diagnosing, prognosing, monitoring, treating and/or preventing a hemopoietic malignancy and/or relapse thereof in a subject. In some embodiments, the methods can include determining an average cellular mass of cells in a sample from the subject and/or detecting one or more molecular signatures in one or more of the cells. In some embodiments, treatment includes administering one or more BCR-ABL tyrosine kinase inhibitors or a pharmaceutical formulation thereof, one or more pre-BCR signaling pathway inhibitors or a pharmaceutical formulation thereof, one or more p38 MAPK inhibitors or a pharmaceutical formulation thereof; or any combination thereof.

Abstract: Described in exemplary embodiments herein are methods, compositions, and kits for diagnosing, prognosing, monitoring, treating and/or preventing a hemopoietic malignancy and/or relapse thereof in a subject. In some embodiments, the methods can include determining an average cellular mass of cells in a sample from the subject and/or detecting one or more molecular signatures in one or more of the cells. In some embodiments, treatment includes administering one or more BCR-ABL tyrosine kinase inhibitors or a pharmaceutical formulation thereof, one or more pre-BCR signaling pathway inhibitors or a pharmaceutical formulation thereof, one or more p38 MAPK inhibitors or a pharmaceutical formulation thereof; or any combination thereof.

Abstract: A building panel is provided. The building panel includes an exterior wall portion, an interior wall portion, a pair of opposing sidewalls, a first end portion and an opposite second end portion. The pair of opposing sidewalls spacing apart the interior wall portion from the exterior wall portion to define a cavity therebetween. The exterior wall portion, the interior wall portion and the pair of opposing sidewalls are arcuate in shape to define the building panel. The first end portion has a slip lock slot extending between the pair of opposing sidewalls. The second end portion has a slip lock tab member extending between the pair of opposing sidewalls. The slip lock slot of the building panel is configured to receive the slip lock tab member of a second building panel to adjoin the first and second building panels in a continuous fashion.

Abstract: In certain example embodiments, the invention provides a method of generating an ex vivo cell-based system comprising dissociating an original tissue sample obtained from a subject into a single cell population; determining an in vivo phenotype of the tissue sample by conducting single-cell RNA analysis on a first portion of the single cells; establishing an ex vivo cell-based system from a second portion of the single cells; and culturing the ex vivo cell-based system in a medium or conditions selected to maintain the in vivo phenotype. In some embodiments, the original tissue sample is a tumor tissue sample, such as a pancreatic ductal adenocarcinoma (PDAC) tumor sample.

Abstract: Inactivated antigens have only been used in avian medicine in parenterally administered vaccines. The only mucosally administered vaccines have been live, modified live, or attenuated vaccines. However, live vaccines have several disadvantages, including the risk of causing disease. Disclosed embodiments concern a composition comprising inactivated bacterial and/or viral antigens that is formulated for mucosal administration to an avian, and a method of using the composition. In certain embodiments, the composition comprises inactivated Clostridium perfringens type A antigens, and/or Salmonella spp. antigens, such as antigens from Salmonella kentucky, Salmonella typhimurium, and/or Salmonella enteriditis, or E. coli antigens. The composition may comprise a polyacrylic acid adjuvant. The composition may be administered to an avian in ovo, during the first 14 days after hatching, or after the first 14 days.

Abstract: Described in exemplary embodiments herein are methods, compositions, and kits for diagnosing, prognosing, monitoring, treating and/or preventing a hemopoietic malignancy and/or relapse thereof in a subject. In some embodiments, the methods can include determining an average cellular mass of cells in a sample from the subject and/or detecting one or more molecular signatures in one or more of the cells. In some embodiments, treatment includes administering one or more BCR-ABL tyrosine kinase inhibitors or a pharmaceutical formulation thereof, one or more pre-BCR signaling pathway inhibitors or a pharmaceutical formulation thereof, one or more p38 MAPK inhibitors or a pharmaceutical formulation thereof or any combination thereof.

Abstract: A system facilitates acquisition of virtual assets by obtaining information about a user and information about one or more computer applications associated with the user. When the user navigates a device to a catalog screen for virtual assets for computer applications, the system automatically presents to the user a filtered listing of applications for which purchasable virtual assets are available to the user that is filtered according to the information about the user and/or the information about one or more computer applications associated with the user. When the user selects an application on the filtered listing, the system automatically presents to the user a filtered catalog of purchasable virtual assets that are available to the user for the selected application that is filtered according to the information about the user and/or the information about one or more computer applications associated with the user.

Abstract: Solar cell (11; 21; 31) having a dielectric coating arranged on a back side of the solar cell (11; 21; 31) which is at least partly covered by at least one planar contact (12; 22; 32), a boundary line (14; 24; 34) of the at least one planar contact (12; 22; 32) having at least one recess (16a, 16b; 26a, 26b, 26c), and method for producing same.

Abstract: Solar cell (11; 21; 31) having a dielectric coating arranged on a back side of the solar cell (11; 21; 31) which is at least partly covered by at least one planar contact (12; 22; 32), a boundary line (14; 24; 34) of the at least one planar contact (12; 22; 32) having at least one recess (16a, 16b; 26a, 26b, 26c), and method for producing same.

Abstract: Disclosed are compounds for treating the symptoms of an acute or chronic disorder mediated by the classical pathway of the complement cascade. The compounds are of Formula I or a solvate, hydrate, pharmaceutically acceptable salt, or prodrug thereof; wherein Ra, Rb, and Rc are as defined in the specification, as are A Z, Q, R1 and R2.

Abstract: The present invention provides a method of reducing the pathogen content of sewage sludge comprising (a) adding to the sludge an effective amount of a phosphorous-containing compound and (b) keeping the phosphorous-containing compound in contact with the sludge for a sufficient time to reduce the amount of pathogens present in the sludge by an amount equivalent to a logarithmic reduction of 2 or more.